prostate cancer

Controversy abounds in prostate cancer. It can involve who and when to screen, and which treatment is the best. A recent study looks at what's been less controversial: the adjunctive use of androgen deprivation therapy. It appears to increase the risk of dementia.
One very sure means of contraception is vasectomy — a minor surgical operation that blocks the transfer of sperm from a man's testes to his urethra (and thus to his partner) by interrupting the tube leading from the testis. One concern has been that somehow this procedure might increase the risk of prostate cancer. But now a meta analysis has found that the risk is virtually non-existent.
A new paper published in the journal Open Forum Infectious Diseases showed that 3 percent of men who undergo prostate biopsies end up being hospitalized within a month. Worse, half of those hospitalizations are due to an infection – and 45 patients died.  
The U.S. Prevention Services Task Force released its 2017 draft recommendations for prostate cancer screening. Here we extensively address the new guidelines, clarify the role of the PSA test, and delve deeper into the topic with Dr. David Samadi, Chairman of Urology and Chief of Robotic Surgery at New York's Lenox Hill Hospital.
Minnesota Gov. Mark Dayton collapsed Monday night in front of legislators while giving the State of the State address. Though he rebounded well, he just disclosed a recent prostate cancer diagnosis. Learn about the proper medical care that's needed when someone faints, and why it happens in the first place. 
A paper was recently published in Cancer on who, and why, patients seek second opinions on prostate cancer. Despite recommendations from both the National Cancer Institute and the American Cancer Society for cancer patients to seek second opinions regarding treatment, there is little substantive medical literature on the behavior surrounding this option.
Actor Ben Stiller recently chronicled how early diagnosis of prostate cancer, using a routine blood test, saved his life. And he's urging all men over 40 to discuss the PSA test with their doctor. However, we here at the Council and other organizations have been critical of it, so it's fitting that we review where science stands on the issue.
Prostate cancer can be indolent, not posing a risk to life — or aggressive, leading to an increased risk of death. A new analysis from the large EPIC study suggests that increases in BMI and waist circumference are associated with an increased risk of the aggressive form, and thus to an increased mortality risk.
A recent study, published online in the journal European Urology, reveals that men who had more frequent ejaculations had a statistically significant reduction in prostate cancer risk. Yes, we can almost hear the collective high-fives taking place among you guys right about now.
An op-ed in the NY Times co-authored by Dr. H. Gilbert Welch decries Medicare's proposal to penalize doctors for ordering the prostate screening tests. That seems like an odd sentiment to endorse, given that we here at the American Council believe that these tests are being given far too often.
A new study shows a strong association between androgen-deprivation therapy for advanced prostate cancer, and the development of Alzheimer's disease. This is a retrospective data-based study, so no change in treatment using ADT is indicated now. Further, prospective studies are needed.
Two studies show that fewer men have been screened for prostate cancer using the PSA test since 2012, when a federal panel advised against routine screenings. With doctors increasingly questioning the test's validity, that's a good thing. But the real key is whether reduction in PSA testing has led to a rise in late-stage or fatal prostate cancer.